ANDREW SPENCE: Open Payments
NPI 1619511854 · QUINTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 97 payments from 19 companies in 2025. Trend: 2023 $979 · 2024 $2,056 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $349 |
| Novo Nordisk Inc | 10 | $193 |
| ABBVIE INC. | 18 | $188 |
| AstraZeneca Pharmaceuticals LP | 4 | $150 |
| Lilly USA, LLC | 7 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $118 |
| SHIELD THERAPEUTICS INC | 2 | $90 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Dexcom, Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: ELIQUIS, FARXIGA, Wegovy, Kerendia, NURTEC ODT, MOUNJARO, VRAYLAR, ACCRUFER.
Industry payments across VA — which companies pay providers there.
